Literature DB >> 1532945

Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells.

R Porat1, D D Poutsiaka, L C Miller, E V Granowitz, C A Dinarello.   

Abstract

Interleukin-1 (IL-1) is a potent stimulator of IL-8 production by fibroblasts and monocytes. In the present study, we asked how much of endotoxin (LPS)-induced IL-8 production by human peripheral blood mononuclear cells was due to IL-1 induced by LPS. Cells were stimulated with either IL-1 beta, LPS, or Borrelia burgdorferi, and total IL-8 was determined by a specific radioimmunoassay. The addition of saturating concentrations of IL-1 receptor antagonist protein (IRAP) reduced the IL-1 beta-, LPS-, and B. burgdorferi-induced IL-8 synthesis by 85, 50, and 40%, respectively. Increasing the concentration of LPS did not affect the reduction in IL-8 synthesis observed in the presence of IRAP. Significant inhibition of the IL-1 beta-induced IL-8 synthesis was observed when IRAP was added 60 or 90 min after IL-1 beta; similarly, IL-8 synthesis after LPS was also reduced by delayed addition of IRAP. These data suggest that the ameliorative effects of IL-1 receptor blockade in models of inflammation and infection may be due, in part, to suppression of IL-1-induced IL-8.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532945     DOI: 10.1096/fasebj.6.7.1532945

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

1.  Photodynamic therapy mediates innate immune responses via fibroblast-macrophage interactions.

Authors:  N Zulaziz; A Azhim; N Himeno; M Tanaka; Y Satoh; M Kinoshita; H Miyazaki; D Saitoh; N Shinomiya; Y Morimoto
Journal:  Hum Cell       Date:  2015-05-22       Impact factor: 4.174

2.  Plasma cytokines associated with febrile status epilepticus in children: A potential biomarker for acute hippocampal injury.

Authors:  William B Gallentine; Shlomo Shinnar; Dale C Hesdorffer; Leon Epstein; Douglas R Nordli; Darrell V Lewis; L Matthew Frank; Syndi Seinfeld; Ruth C Shinnar; Karen Cornett; Binyi Liu; Solomon L Moshé; Shumei Sun
Journal:  Epilepsia       Date:  2017-04-27       Impact factor: 5.864

3.  Clinical, hematologic, and immunologic effects of interleukin-10 in humans.

Authors:  A C Fuchs; E V Granowitz; L Shapiro; E Vannier; G Lonnemann; J B Angel; J S Kennedy; A R Rabson; E Radwanski; M B Affrime; D L Cutler; P C Grint; C A Dinarello
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

4.  Differential antibiotic-induced release of endotoxin from gram-negative bacteria.

Authors:  S E Bucklin; Y Fujihara; M C Leeson; D C Morrison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

5.  Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.

Authors:  A J Puren; G Fantuzzi; Y Gu; M S Su; C A Dinarello
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

6.  Effect of treatment with interleukin-1 receptor antagonist on the development of carrageenan-induced pleurisy in the rat.

Authors:  K P Meyers; C L Czachowski; J W Coffey
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

7.  Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.

Authors:  Malte Bachmann; Katharina Horn; Ina Rudloff; Itamar Goren; Martin Holdener; Urs Christen; Nicole Darsow; Klaus-Peter Hunfeld; Ulrike Koehl; Peter Kind; Josef Pfeilschifter; Peter Kraiczy; Heiko Mühl
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

8.  Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits.

Authors:  K Aiura; J A Gelfand; J F Burke; R C Thompson; C A Dinarello
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.

Authors:  J Mancilla; P García; C A Dinarello
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

10.  Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.

Authors:  M C Kennedy; J T Rosenbaum; J Brown; S R Planck; X Huang; C A Armstrong; J C Ansel
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.